|
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer
|
May 15, 2023
|
PC3I Authors Charu Aggarwal; Christopher A. D’Avella; Melina Marmarelis |
The Oncologist
|
|
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung Cancer
|
June 4, 2023
|
PC3I Authors Charu Aggarwal; Melina Marmarelis; Ronac Mamtani |
JAMA Oncology
|
|
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens
|
July 14, 2023
|
PC3I Authors Charu Aggarwal; Christopher A. D’Avella; Ronac Mamtani; Melina Marmarelis |
Clinical Lung Cancer
|
|
Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer
|
July 27, 2023
|
PC3I Authors Charu Aggarwal; Melina Marmarelis; Dylan G. Scholes; Peter Gabriel; Larry Shulman; Justin Bekelman |
JCO Precision Oncology
|
|
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
|
August 31, 2023
|
PC3I Authors Michelle Iocolano; Catherine Lai; Charu Aggarwal; Melina Marmarelis |
International Journal of Radiation Oncology, Biology, Physics
|
|
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
|
October 9, 2023
|
PC3I Authors Michelle Iocolano; Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella |
Clinical Lung Cancer
|
|
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
|
October 22, 2023
|
PC3I Authors Michelle Iocolano; Charu Aggarwal; Melina Marmarelis |
International Journal of Radiation Oncology, Biology, Physics
|
|
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)
|
November 23, 2023
|
PC3I Authors Melina Marmarelis |
Lung Cancer
|
|
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
|
February 16, 2024
|
PC3I Authors Melina Marmarelis |
JTO Clinical and Research Reports
|
